{"retracted":false,"update":{"timestamp":1376524800000,"doi":"10.1016/j.bmcl.2013.06.020","type":"err"},"doi":"10.1016/j.bmcl.2013.05.007","journal":"Bioorganic & Medicinal Chemistry Letters","publisher":"Elsevier BV","title":"Corrigendum to “Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation” [Bioorg. Med. Chem. Lett. 23 (2013) 3741–3748]"}
